Ftse Mib
37.582,05
0,00%
DAX
22.034,13
0,00%
S&P 500
6.068,50
0,03%
NASDAQ
19.643,86
-0,36%
Bitcoin
96.048,38
0,31%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Shuttle Pharmaceuticals Holdings Inc (SHPH) Shuttle Pharmaceuticals Holdings Inc (SHPH) Notizie

Shuttle Pharmaceuticals Holdings Inc

SHPH
0,6704
-0,0336 (-4,77%)
12 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202501:34EDGAR2Form 5/A - Annual statement of changes in beneficial..
28/1/202522:10EDGAR2Form 8-K - Current report
21/1/202515:00EDGAR2Form 8-K - Current report
21/1/202515:00GLOBEShuttle Pharma Reaches Milestone in Patient Enrollment for..
13/1/202514:56APSInvestors Watching Two Small-Caps for News on Potential..
07/1/202515:00EDGAR2Form 8-K - Current report
07/1/202515:00GLOBEShuttle Pharma to Participate in the Lytham Partners 2025..
19/12/202415:00EDGAR2Form 8-K - Current report
19/12/202415:00GLOBEShuttle Pharma Enters into Sponsored Research Agreement with..
26/11/202415:00EDGAR2Form 8-K - Current report
26/11/202415:00GLOBEShuttle Pharma Expands Patient Enrollment for Phase 2..
13/11/202423:16EDGAR2Form 8-K - Current report
13/11/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202423:00GLOBEShuttle Pharma Provides Third Quarter 2024 Corporate Update
30/10/202402:05GLOBEShuttle Pharmaceuticals Holdings, Inc. Announces Pricing of..
29/10/202421:05GLOBEShuttle Pharma Pays Off Senior Secured Convertible Note
29/10/202417:55APSMicro Cap Company Is Soaring On Phase 2 Trial Update
29/10/202414:00EDGAR2Form 8-K - Current report
29/10/202414:00GLOBEShuttle Pharma Doses First Patients in Phase 2 Clinical..
28/10/202421:05EDGAR2Form 8-K - Current report
28/10/202421:05GLOBEShuttle Pharma Completes Clinical Trial Site Enrollment for..
28/10/202414:00EDGAR2Form 8-K - Current report
28/10/202414:00GLOBEShuttle Pharmaceuticals to Present at the 2024 ThinkEquity..
25/10/202414:52EDGAR2Form 8-K - Current report
17/10/202423:17EDGAR2Form 8-K - Current report
09/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202415:00GLOBEShuttle Pharma Expands Clinical Trial Site Enrollment for..
13/9/202423:00EDGAR2Form 8-K - Current report
10/9/202423:23EDGAR2Form 8-K - Current report
05/9/202415:00GLOBEShuttle Pharma Announces Issuance of U.S. Patent for..
04/9/202422:26EDGAR2Form 8-K - Current report
04/9/202422:15GLOBEShuttle Pharma Provides Second Quarter 2024 Corporate Update
04/9/202403:54EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/9/202403:52EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
04/9/202403:51EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28/8/202415:00EDGAR2Form 8-K - Current report
28/8/202415:00GLOBEShuttle Pharma Regains Compliance with Nasdaq Minimum Bid..
26/8/202422:10EDGAR2Form 8-K - Current report
26/8/202422:10GLOBEShuttle Pharma Receives Notice of Nasdaq Non-Compliance with..
14/8/202422:15EDGAR2Form 8-K - Current report
14/8/202422:10GLOBEShuttle Pharma Ready to Enroll Patients in Phase 2 Clinical..
13/8/202412:08EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
07/8/202414:00EDGAR2Form 8-K - Current report
01/8/202415:45EDGAR2Form 8-K - Current report
19/7/202415:00GLOBEShuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM..
16/7/202422:59EDGAR2Form 8-K - Current report
18/6/202415:00EDGAR2Form 8-K - Current report
18/6/202415:00GLOBEShuttle Pharma Appoints Timothy Lorber as Chief Financial..
10/6/202412:12EDGAR2Form PRE 14A - Other preliminary proxy statements
22/5/202422:15EDGAR2Form 8-K - Current report
Apertura: 0,666 Min: 0,6594 Max: 0,711
Chiusura: 0,704

La tua Cronologia

NASDAQ
SHPH
Shuttle Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci